Aligos Therapeutics Inc. Revenue 2020–2025
Aligos Therapeutics Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Aligos Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 2.8 M, a 809.97% increase year-over-year.
- Aligos Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 4.8 M, a 18.51% increase year-over-year.
- Aligos Therapeutics Inc. annual revenue for 2025 was 2.2 M, a 39.46% decrease from 2024.
- Aligos Therapeutics Inc. annual revenue for 2024 was 3.6 M, a 41.67% decrease from 2023.
- Aligos Therapeutics Inc. annual revenue for 2023 was 6.2 M.
- Aligos Therapeutics Inc. annual revenue for 2022 was 0.
Aligos Therapeutics Inc. (ALGS) — Frequently Asked Questions
Aligos Therapeutics Inc. (ALGS) is a publicly traded US company. It has a market capitalization of $52M. In fiscal 2025 it reported revenue of $2M and net income of -$24M. Explore ALGS's stock price, financial statements, earnings history, margins and key ratios below.
What is Aligos Therapeutics Inc.'s market cap?
Aligos Therapeutics Inc. (ALGS) has a market capitalization of $52M.
What is the ALGS stock price?
ALGS trades at $5.28 (+2.33% on the day).
How much revenue does Aligos Therapeutics Inc. make?
Aligos Therapeutics Inc. reported revenue of $2M in fiscal 2025.
Is ALGS profitable?
In fiscal 2025, Aligos Therapeutics Inc. reported net income of -$24M.